Susquehanna Fundamental Investments LLC Purchases Shares of 343,162 Centene Co. (NYSE:CNC)

Susquehanna Fundamental Investments LLC acquired a new position in Centene Co. (NYSE:CNC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 343,162 shares of the company's stock, valued at approximately $20,789,000. Susquehanna Fundamental Investments LLC owned approximately 0.07% of Centene at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Capital Advisors Ltd. LLC increased its stake in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after buying an additional 177 shares in the last quarter. Hurley Capital LLC purchased a new stake in Centene in the 4th quarter worth $26,000. Rialto Wealth Management LLC purchased a new stake in Centene in the 4th quarter worth $30,000. OFI Invest Asset Management purchased a new stake in Centene in the 4th quarter worth $33,000. Finally, SRS Capital Advisors Inc. increased its stake in Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock worth $38,000 after buying an additional 267 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CNC has been the subject of several research reports. Guggenheim reissued a "neutral" rating on shares of Centene in a report on Tuesday. Jefferies Financial Group cut their price target on Centene from $64.00 to $61.00 and set a "hold" rating for the company in a report on Tuesday. Argus cut Centene from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Barclays decreased their price objective on Centene from $93.00 to $84.00 and set an "overweight" rating on the stock in a report on Monday. Finally, StockNews.com cut Centene from a "strong-buy" rating to a "buy" rating in a report on Monday. Seven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $79.77.

Centene Stock Up 0.1 %

Shares of CNC traded up $0.03 during midday trading on Thursday, reaching $59.88. 2,710,054 shares of the stock were exchanged, compared to its average volume of 4,703,031. Centene Co. has a 52 week low of $55.03 and a 52 week high of $80.59. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The company's 50 day moving average is $60.19 and its two-hundred day moving average is $60.71. The company has a market capitalization of $29.80 billion, a P/E ratio of 9.60, a PEG ratio of 0.80 and a beta of 0.53.

Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $46.62 billion for the quarter, compared to the consensus estimate of $43.16 billion. During the same quarter in the prior year, the company earned $2.26 EPS. The business's revenue was up 15.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.